QNRX
Quoin Pharmaceuticals
QNRX
QNRX
7 hedge funds and large institutions have $1.45M invested in Quoin Pharmaceuticals in 2018 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.
Holders
7
Holders Change
-1
Holders Change %
-12.5%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Morgan Stanley
New York
|
$121K |
| 2 |
2
UBS Group
Zurich,
Switzerland
|
$11K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
SM
1
Sabby Management
Miami Beach,
Florida
| $798K | 111,540 | -132,440 | -54% |
|
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $439K | 61,429 | -6,533 | -10% |
|
|
3
Morgan Stanley
New York
| $121K | 16,869 | +2,000 | +13% |
|
4
Citigroup
New York
| $70K | 9,740 | – | – |
|
|
5
UBS Group
Zurich,
Switzerland
| $11K | 1,520 | +1,520 | New |
|
|
APA
6
American Portfolios Advisors
Holbrook,
New York
| $7.15K | 1,000 | – | – |
|
|
MIFH
7
Migdal Insurance & Financial Holdings
Petach Tikva,
Israel
| – | – | -1,555 | Closed |
|
8
Bank of America
Charlotte,
North Carolina
| – | – | -5 | Closed |
|
9
CIBC Private Wealth Group
Atlanta,
Georgia
| $0 | 50 | – | – |
|